1435 - Processing and Cryopreservation of Male and Female Gonadal Tissue and Gametes Prior to or after Gonadotoxic Treatment to Preserve Fertility for the Future

Page last updated: 29 June 2018

Application Detail

Status

Open

Description of Medical Service

The Applicant is seeking a review of the following proposed medical services:

Processing and handling of ovarian tissue in preparation for cryostorage as part of fertility preservation treatment for female patients who have or will receive gonadotoxic treatment.

Processing and handling of semen in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Processing and handling of testicular tissue in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Description of Medical Condition

The proposed patient population is defined by the requirement of gonadotoxic therapy. Two distinct patient populations may be defined:
  1. Patients diagnosed with malignancy
  2. Patients diagnosed with non-malignant conditions receiving gonadotoxic treatment

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Consultation Protocol (PDF 1473 KB)
Consultation Protocol (Word 908 KB)

Assessment Report

-

Public Summary Document

Public Summary Document - Part A - Male (PDF 506 KB)
Public Summary Document - Part A - Male (Word 619 KB)

Public Summary Document - Part B - Female (PDF 811 KB)
Public Summary Document - Part B - Female (Word 388 KB)

Meetings for this Application

PASC

11 - 12 August 2016

ESC

5 October 2017 - Part A - Male
8-9 February 2018 - Part B - Female

MSAC

23 November 2017 - Part A - Male
28-29 March 2018 - Part B - Female